Skip to Content

Cancer-Associated Thrombosis

Abnormal blood clotting can result from the genetic mutations involved in the development of cancer. One in five cancer patients faces the possibility of experiencing a dangerous blood clot or a cancer-associated thrombosis—a leading cause of death for these patients.

With a very high probability of developing blood clots comes a very high risk of bleeding complications. Deep vein thrombosis (DVT) is a type of clot that develops in the deep veins of the body, often in the legs. If the clot breaks loose, it can end up in the lungs and cause a life-threatening pulmonary embolism (PE). Both conditions require immediate medical attention.

Preventive strategies offer cancer patients the best chance of avoiding the development of blood clots. At NorthShore, our vascular medicine specialists carefully optimize the use of preventive medication strategies and tailor the choice of anticoagulation therapies best suited to your unique situation. In collaboration with the Kellogg Cancer Center, our Cancer-Associated Thrombosis clinic attends to your individualized needs during the entire disease trajectory.

Contributing to advances in patient care through innovative research, NorthShore is currently participating in a clinical trial focused on the use of novel anticoagulants for the treatment and prevention of cancer-associated thrombosis.

For More Information

To request additional information or schedule an appointment with one of our vascular medicine specialists, please call 847.663.8050.